Compare Moderna, Inc. (MRNA) vs Strategy Inc. (MSTR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Moderna, Inc. vs Strategy Inc. — how do they compare? Moderna, Inc. trades at $59.73 (market cap $23.60B), while Strategy Inc. trades at $101.97 (market cap $35.47B). The key difference: Strategy Inc. is the larger of the two by market cap, and Moderna, Inc. is trading nearer its 52-week high, Strategy Inc. nearer its low. Which is the better fit depends on your goals.
| MRNA | MSTR | |
|---|---|---|
Market Cap | $23.60B | $35.47B |
Sector | Health | Technology |
52-Week High | $81.80 | $426.40 |
52-Week Low | $22.36 | $82.31 |
Enterprise Value | $19.70B | $50.50B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →About Strategy Inc.
MicroStrategy Inc is a provider of enterprise analytics and mobility software. It offers MicroStrategy Analytics platform that delivers reports and dashboards and enables users to conduct ad hoc analysis and share insights through mobile devices or the Web
Read more on MSTR →
